A Hyundai Motor Co.-led group will buy an 80-percent stake, worth up to 900 billion won, in US robotics firm Boston Dynamics Inc. from Japanese investment firm SoftBank Group.
Hyundai Motor Co. and Hyundai Motor Chairman Chung Euisun will take 30 percent and 20 percent of the deal, and two subsidiaries, Hyundai Mobis and Hyundai Glovis, will pay for the remainder, the firm said.
The board of directors at Hyundai Motor and its two affiliates, Hyundai Mobis and Hyundai Glovis, approved the deal worth between 800 billion won to 900 billion won aimed at expanding the robotics business to tap into related industries and create synergy with future businesses.
Hyundai Motor hopes to finalize the deal, which requires regulatory approvals in South Korea and the United States, within the first half of next year.
SoftBank acquired Boston Dynamics from Google owner Alphabet Inc. in 2017.
Boston Dynamics is yet to make a profit out of its famous dog-like robot Spot, which became available for sale this year for $75,000 per unit.
It is Hyundai Motor Group's first M&A deal after Chung Euisun officially took the helm of the company in October.
Chung vowed to make the company a future mobility provider.


Tesla Roadster Reveal Could Feature SpaceX Thrusters in August
Lockheed Martin Secures $153.5 Million in U.S. Defense Contracts
Google to Buy Spirit Airlines Business Data for $10 Million to Train AI
Nvidia Eyes $3 Billion Investment in SoftBank-Backed AI Data Center
Micron Stock Upgraded to Buy as New Street Sees $2 Trillion Valuation Potential
SEC Sues Former Tricolor Executives Over $1.9 Billion Investor Fraud Scheme
Hermès Stock Downgraded by RBC as Luxury Growth Premium Narrows
Nvidia’s $500 Billion AI Infrastructure Push Wins Morgan Stanley Support
Alibaba Sells Lingxi Games for Over $1.5 Billion Amid AI Push
Schott Pharma Stock Rises as Barclays Upgrades Rating on Growth Outlook
OpenAI Tightens AI Safety Monitoring After Security Incidents
J.P. Morgan Upgrades SanDisk, Sets $2,250 Price Target on AI NAND Growth
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback
Shein Targets $26B-$27B Valuation for Hong Kong IPO
Alphabet Shifts AI Strategy Toward Commercial Growth, Goldman Sachs Says
Alphabet’s SpaceX Investment Soars 100-Fold to $94 Billion
Synlait Milk Denies Fonterra, a2 Milk Takeover Talks 



